Ionis Pharmaceuticals IONS Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions?
- Ionis Pharmaceuticals (IONS) reported unrecognized tax benefits increases resulting from current period tax positions of $1.79M in Q4 2025.
- How has Ionis Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions changed year-over-year?
- Ionis Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions increased by 96.2% year-over-year, from $912.5K to $1.79M.
- What is the long-term trend for Ionis Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's unrecognized tax benefits increases resulting from current period tax positions has grown at a 87.7% compound annual growth rate (CAGR), from $2.03M to $7.16M.
- What does unrecognized tax benefits increases resulting from current period tax positions mean?
- The addition to tax reserves for new tax positions taken in the current year that may be challenged by authorities.
- How do you interpret unrecognized tax benefits increases resulting from current period tax positions?
- An increase indicates a more aggressive or uncertain current tax strategy, potentially increasing future audit exposure.
- How does unrecognized tax benefits increases resulting from current period tax positions compare across companies?
- Used by investors to gauge the current-year tax risk appetite of the firm.